Do low estradiol and progesterone in menopause make sleep and stress responses less resilient?

During menopause, the sharp decline in estradiol and progesterone fundamentally destabilizes the neural and endocrine networks that regulate sleep, temperature, and stress responses.

Thermoregulatory and GABAergic sleep disruption

• KNDy neuron hyperactivity: Estradiol withdrawal removes critical inhibitory feedback on kisspeptin–neurokinin B–dynorphin (KNDy) neurons in the hypothalamic arcuate nucleus. This drives excessive neurokinin B signaling to the preoptic area, narrowing the thermoneutral zone and triggering sleep-disruptive vasomotor symptoms.
• GABAergic impairment: Progesterone depletion reduces its metabolite, allopregnanolone, which is a potent positive allosteric modulator of GABA-A receptors. The loss of this inhibitory influence decreases sleep resilience and promotes physiological hyperarousal.

HPA axis vulnerability

• Sensitized stress response: Deprived of ovarian hormone feedback on corticotropin-releasing hormone (CRH) and ACTH, the hypothalamic-pituitary-adrenal (HPA) axis becomes hyper-reactive, leading to elevated nocturnal cortisol levels.
• Pathological feedback loop: Elevated stress-axis activity degrades sleep architecture, reducing restorative slow-wave sleep (SWS) and increasing wake after sleep onset (WASO). The resulting physical fragmentation of sleep further drives bedtime cortisol elevations, compounding sleep disruption.

Bottom line

• The decline of ovarian hormones during menopause severely undermines sleep resilience through a dual mechanism of hypothalamic thermoregulatory instability and depleted GABAergic signaling, which renders sleep architecture highly vulnerable to HPA-axis hyper-reactivity.